193) Treatment options for cocaine dependence a |
194) Several treatment options (n = 5) that do not in |
195) ood or saliva: their detection can affect treatment options and potential risk-reduc |
196) sin-aldosterone system (RAAS), multimodal treatment options are available with miner |
197) tudies and their relationships: different treatment options are illustrated as nodes |
198) Current treatment options are limited by the devel |
199) Current treatment options are limited in the face |
200) KI diagnosis in COVID-19 patients and new treatment options are required to reduce t |
201) patients with breast cancer, but optimal treatment options as well as risks associa |
202) k of non-pharmacological and non-invasive treatment options call for new and innovat |
203) The efficacy of several different treatment options can be assessed with eit |
204) ions with feedback loops and personalized treatment options can build user agency. |
205) del estimating the benefit of alternative treatment options for individual patients, |
206) notype and suggests a number of potential treatment options. |
207) universal resulting in reduced inpatient treatment options. |
208) nscranial magnetic stimulation (TMS) as a treatment in DoC to determine patient and |
209) psychosocial) of non-adherence to anti-TB treatment in HILI settings were included.R |
210) associated with non-adherence to anti-TB treatment in HILI settings. |
211) Primary research evaluating neoadjuvant treatment in T4 colon cancer were included |
212) utyrate (GABA), and N-methyl-GABA in N+OC treatment in adolescent animals. |
213) veral days following cessation of ethanol treatment in an early postnatal mouse mode |
214) ing 'off-the-shelf' S309-CAR-NK cells for treatment in high-risk individuals as well |
215) he majority preferred receiving in-person treatment in primary care clinics. |
216) n prescribing patterns for acute migraine treatment in the ED setting. |
217) Interestingly, statin treatment in the d-flow condition (LCA+sta |
218) rature suggests the role of mentalization treatment in the remission of symptoms for |
219) Statin treatment in the s-flow condition (RCA+sta |
220) as many patients as possible to the best treatment, in particular, when a trial for |
221) While we use a subject-specific treatment effect and Bayesian posterior pr |
222) A strong relationship between treatment effect and age provides insights |
223) The outcomes demonstrate a strong treatment effect and suggest that targetin |
224) length of a spring corresponds to a study treatment effect and the stiffness of the |
225) consistent, there is potential for biased treatment effect estimates, inflated type |
|